Making Imodium Rx-Only No Help On Curbing Opioid Abuse – CHPA
Executive Summary
Making OTC diarrhea remedy loperamide Rx-only is unlikely to reduce abuse and would cause problems for millions of US consumers who depend on the product, says the Consumer Healthcare Products Association, responding to a petition advocating the change.
You may also be interested in...
FDA Looks At OTC Loperamide Packaging To Curb Opioid-Related Abuse
Ingredient in J&J's Imodium and numerous OTC generics acts on opioid receptors in the gut to slow movement in the intestines and decrease bowel movements, but dosing at much higher than recommended amounts can lead to serious problems including severe heart rhythm problems and death.
FDA Looks At OTC Loperamide Packaging To Curb Opioid-Related Abuse
Ingredient in J&J's Imodium and numerous OTC generics acts on opioid receptors in the gut to slow movement in the intestines and decrease bowel movements, but dosing at much higher than recommended amounts can lead to serious problems including severe heart rhythm problems and death.
Loperamide Abuse Triggers Look At Potential Label Warning
Monitoring of AERs prompts concern about the ingredient used in OTC anti-diarrheal products, CDER says a day after it noted adverse event reports in announcing concerns about a risk of serious bleeding linked to use of OTC antacid/aspirin products.